Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

BACKGROUND: Neurologic toxicities with immune therapy are rare, but can cause devastating and often permanent injury when they occur. Although there is increasing interest in the potential synergism between immune therapy and radiation, it is possible that such combinations may lead to a greater num...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Victoria A., Simpson, Daniel R., Daniels, Gregory A., Piccioni, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303890/
https://www.ncbi.nlm.nih.gov/pubmed/30577851
http://dx.doi.org/10.1186/s40425-018-0471-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303890/
https://www.ncbi.nlm.nih.gov/pubmed/30577851
http://dx.doi.org/10.1186/s40425-018-0471-2

Ejemplares similares